Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 139 Breast Neoplasms 31 Prostatic Neoplasms 29 Insulin Resistance 28 Obesity 19 Pancreatic Neoplasms 13 Neoplasms 12 Infertility 12 Endometrial Neoplasms 12 Carcinoma, Non-Small-Cell Lung 12 Colorectal Neoplasms 11 Anovulation 9 Lung Neoplasms 8 Metabolic Syndrome 7 Melanoma 7 Hyperandrogenism 7 Glioblastoma 7 Diabetes Mellitus 7 Squamous Cell Carcinoma of Head and Neck 6 Neoplasm Metastasis 6 Rectal Neoplasms 5 Adenocarcinoma 5 Weight Loss 4 Urinary Bladder Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 4 Head and Neck Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Adenocarcinoma of Lung 4 Uterine Cervical Neoplasms 3 Recurrence 3

Interventions

Exercise 6 Transcranial Direct Current Stimulation 4 Neuropsychological Tests 4 Walking 3 Memantine 3 Tablets 2 Standard of Care 2 Patient Reported Outcome Measures 2 Methods 2 Electroencephalography 2 Donepezil 2 Cognitive Behavioral Therapy 2 mazdutide 1 lime 1 enzalutamide 1 blueberry extract 1 beta Carotene 1 acetaminophen, aspirin, caffeine drug combination 1 Vitamin E 1 Vitamin D 1 Ultraviolet Therapy 1 Transcranial Magnetic Stimulation 1 Time 1 Therapeutics 1 Tai Ji 1 Surveys and Questionnaires 1 Sugars 1 Sodium Chloride 1 Sirolimus 1 Silymarin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cognitive Dysfunction × Metformin × Clear all

NCT05230758 2026-05-01

Met Med Can

The Hospital for Sick Children

Phase 3 Recruiting

Medulloblastoma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡